Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CASP3 | P42574 | 4/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | MDM4 | O15151 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | FABP7 | O15540 | 1/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29696612 | 0.90 | CASP3 (0.50) | KMT2ACASP3OPRD1EPHX2MDM4 | |
| SCHEMBL24579314 | 0.90 | CASP3 (0.50) | KMT2ACASP3OPRD1EPHX2MDM4 | |
| SCHEMBL29696650 | 0.84 | KMT2A (0.51) | KMT2ACASP3OPRD1EPHX2MDM4 | |
| SCHEMBL24579293 | 0.81 | CASP3 (0.41) | KMT2ACASP3OPRD1EPHX2 | |
| SCHEMBL30861937 | 0.81 | CASP3 (0.41) | KMT2ACASP3OPRD1EPHX2 | |
| SCHEMBL30367121 | 0.78 | KMT2A (0.56) | KMT2ACASP3OPRD1EPHX2MDM4 | |
| SCHEMBL24406209 | 0.78 | KMT2A (0.56) | KMT2ACASP3OPRD1EPHX2MDM4 | |
| SCHEMBL24579357 | 0.77 | CASP3 (0.49) | KMT2ACASP3 | |
| SCHEMBL28803723 | 0.77 | OPRD1 (0.56) | KMT2ACASP3OPRD1EPHX2FABP7 | |
| SCHEMBL26605915 | 0.76 | KMT2A (0.49) | KMT2ACASP3OPRD1EPHX2MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022138891-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | 中外製薬株式会社 | 2022-06-30 | — | — | WO | disclosed |